Global 3D Cell culture Market-Growth, Trends, Application and Forecast (2017-2022)

Summary

Orbis Research Present’s Global 3D Cell culture Market-Growth, Trends and Forecast (2017-2022) has been prepared based on an in-depth market analysis with inputs from industry experts.

Description

The Global 3D Cell Culture Market was valued at an estimated $XX million in 2013 and is poised to grow at a CAGR of XX% from 2013 to 2018, to reach $XX million by 2018. The market is expected to reach USD XX million by 2022, growing at a CAGR of XX% during the forecast period of 2017 to 2022.
Cell culture is a process by which prokaryotic cells or eukaryotic cells are artificially grown outside their natural environment in a laboratory under controlled conditions. 3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Research laboratories and institutes, hospitals, and biopharmaceutical and biotechnology companies are adopting 3D cell culture for better outputs and the adoption rate is posed to increase rapidly in the near future.

The Huge investment by Life science companies for R&D, Development of automated large-scale cell culture systems, Rise in Research and Development Investments, Rising need for organ transplantation, Use of 3D Cell Culture models as an alternative tool for in vivo testing and increasing focus on regenerative medicine are key factors propelling the growth of the market. However, Lack of experienced and skilled professionals, Budget restriction for small and medium sized laboratories, Lack of consistency in 3D cell culture products and stringent process controls for advanced handling capabilities are turning out to be restraints for the market.

Get a PDF Sample of Global 3D Cell culture Market Report at: http://www.orbisresearch.com/contacts/request-sample/220467

The 3D Cell culture market is segmented on the basis of Technology, Applications and the End user. The Technology segment is further categorized into Extracellular matrices (Scaffolds), Bioreactors, Gels, Scaffold-free platforms, Microchips and others. The Applications segment includes Research, Drug discovery, Tissue engineering, Clinical applications, Stem cell biology and others. By End user, the 3D Cell culture market is segmented into Research laboratories and institutes, Biotechnology and pharmaceutical industries, Hospitals and diagnostic centers and others.
This report have been geographically segmented into North America, Europe, Asia-Pacific, Middle East & Africa and South America.

The North American region have been further segmented into USA, Canada and Mexico. The Europe region have been sub-divided into Germany, France, UK, Spain, Italy, Scandinavia, Benelux and Rest of Europe. The Asia-Pacific market have been segmented into Japan, China, India, South Korea, Australia & New Zealand and Rest of Asia-Pacific. The Middle East & African market have been subdivided into GCC countries, South Africa and rest of Middle East and Africa. The South American market have been segmented into Brazil, Argentina and rest of South America.

Europe dominates the 3D cell culture market. The U.K. represents the largest market for 3D cell culture in the region. This is due to rising investment in 3D cell culture market, increasing research related activities, and 3D cell culture's ability to replace the animal in research and pharmaceutical testing. The APAC region presents an array of opportunities for growth and is likely to be getting attention of new investors in the 3D cell culture market. Asia-pacific region is expected to grow at the highest CAGR due to increased healthcare awareness, improved economic growth, low operating cost and increased outsourcing. Significant new product launches, mergers and acquisitions, collaborations, joint ventures are some of the industry trends that are playing a major role for the market growth.

The key players in the market are:

3D Biomatrix, Inc (U.S.), 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions Inc, (U.S.), InSphero AG (Switzerland), Lonza Group (Switzerland), Nano 3D Biosciences (U.S.), Nanofiber Solutions Incorporation (U.S.), Sigma Aldrich Corporation (U.S.) and Reinnervate Ltd, (A subsidiary of ReproCELL) (U.K.). and others.

Place a Purchase Order for Global 3D Cell culture Market Report at: http://www.orbisresearch.com/contact/purchase/220467

Key Deliverables

Market analysis for the Global 3D Cell culture market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global 3D Cell culture market
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

This release was published on openPR.